Figure 1From: ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy Kaplan-Meier curves for ERCC1 C8092A (A) and T19007C (B) polymorphisms in T4 breast cancer patients. Back to article page